So after watching this for a few years I have finally bought in. I'm no expert when it comes to biotech but last year I felt the risk of FDA rejection was too
high for me.
I made money once from a US biotech called Sarepta and learned then how long and tortuous the pathway to approval and then commercialisation can be. I have a feeling that MSB is now on a track that justifies the still high risk of investing. It is a binary play: it will either be zero or $10+, depending on your timeline (see next point).
My timeline for approval and commercialisation is 12 - 36 months. 12 being the best case, longer than 36 and I'll sell out and take the loss.
I note that this forum has some deep experts, far more knowledgeable than me, on the dark ways of the FDA approvals process. Anyone want to challenge my timeline?
So after watching this for a few years I have finally bought in....
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |